Humbly we consider that developing and commercializing our products is the most important contribution we can give to human beings. The successful IPO, which we completed during 2017, was a key step to secure our Company’s funding and hence enable development, commercializing and delivery of our life quality increasing product portfolio. We mean that our corporate responsibility is integrated in our business model. Health and quality of life concern us deeply.
Using antibiotics locally, means it is efficiently used where needed and can decrease the risk with surgical orthopedic procedures.
Over the years our Company has supported charities such as Barncancerfonden (Swedish Childhood Cancer Foundation).